ライフサイエンスコーパス: translocator

1 esumed to somehow serve as both receptor and translocator.

2 red N-terminal translocation domain into the translocator.

3 ir it recruits another Cir protein as its OM translocator.

4 f the SBP or the selectivity provided by the translocator.

5 that ColN uses OmpF both as its receptor and translocator.

6 membrane by secreting two proteins known as translocators.

7 nstitution and analysis of membrane-inserted translocators.

8 I (COI)] or nuclear DNA [adenine nucleotide translocator 1 (ANT1) and nicotinamide nucleotide transh

9 art and muscle isoform of adenine nucleotide translocator 1 (ANT1) are associated with autosomal-domi

10 , cardiac troponin-I, and adenine nucleotide translocator 1 (ANT1), have been identified as autoantig

11 we identified Plastidal glycolate glycerate translocator 1 (PLGG1) as a candidate core photorespirat

12 Ten homozygous null (adenine nucleotide translocator-1(-/-)) patients monitored over a median of

13 art-muscle isoform of the adenine nucleotide translocator-1.

14 nce fimbriae (AAF), dispersin, the dispersin translocator Aat, and the Aai type VI secretion system,

15 Infection enhanced AHR/AHR nuclear translocator and AHR/RELB DNA binding and stimulated the

16 the possibility that it functions as both a translocator and an effector.

17 ecretion of type III secretion system (T3SS) translocator and effector proteins.

18 h degradation involve the adenine nucleotide translocator and mitochondrial permeability transition p

19 e AHR and heterodimeric partners AHR nuclear translocator and RELB are robustly expressed, and AHR an

20 on factors-aryl hydrocarbon receptor nuclear translocator and sine oculis homeobox 1-and found that t

21 th mitochondrial proteins adenine nucleotide translocator and voltage-dependent anion channel, result

22 Basal expression of AhR, the AhR nuclear translocator, and the CYP1 family members do not predict

23 ot its dimerization partner, the AHR nuclear translocator, and the repressive effects of TIPARP on AH

24 ectedly, we find that the adenine nucleotide translocator (ANT) complex is required for mitophagy in

25 We have identified the adenine nucleotide translocator (ANT) isoforms ANT1 and ANT2 that are prese

26 (3-) via the electrogenic adenine nucleotide translocator (ANT) located in the mitochondrial inner me

27 ent anion channel (VDAC), adenine nucleotide translocator (ANT), and cyclophilin D (CyPD).

28 the conclusion that type 4 pili and the DNA translocator are distinct systems.

29 First, the pore-forming translocators are released.

30 rs through a distal needle 'tip complex' and translocators are secreted before effectors.

31 Unfolded translocators are secreted through the T3S needle prior

32 First, the translocators are secreted to form a pore in the host ce

33 HIF1alpha)/aryl hydrocarbon receptor nuclear translocator (ARNT) and HIF2alpha/ARNT (HIF2) proteins i

34 on partner aryl hydrocarbon receptor nuclear translocator (ARNT) belong to the basic helix-loop-helix

35 rtner, the aryl hydrocarbon receptor nuclear translocator (ARNT) in the hematopoietic system to ablat

36 ression of aryl hydrocarbon receptor nuclear translocator (ARNT) is critical during the development o

37 nd p57, we identify Aryl hydrocarbon nuclear translocator (Arnt) messenger RNA (mRNA) as a novel targ

38 ggest that aryl hydrocarbon receptor nuclear translocator (ARNT) plays an important role in the modul

39 Since dimerization with the AhR Nuclear Translocator (ARNT) protein, occurring through the Helix

40 heterodimerization partner, the AhR nuclear translocator (Arnt) protein.

41 expressed aryl hydrocarbon receptor nuclear translocator (ARNT) subunit, which dimerize via basic he

42 (HIF-alpha.aryl hydrocarbon receptor nuclear translocator (ARNT)) requires association with several t

43 ression of aryl hydrocarbon receptor nuclear translocator (ARNT), a critical component of the hypoxia

44 ', and the aryl hydrocarbon receptor nuclear translocator (ARNT), did not.

45 e with the aryl hydrocarbon receptor nuclear translocator (ARNT), to form functional transcription co

46 a subunit, aryl hydrocarbon receptor nuclear translocator (ARNT).

47 ha, HIF-2alpha, and aryl hydrocarbon nuclear translocator (ARNT).

48 nt (XRE) in partnership with the AhR nuclear translocator (Arnt).

49 -alpha and aryl hydrocarbon receptor nuclear translocator (ARNT, also known as HIF-beta) heterodimer

50 f the gene encoding aryl hydrocarbon nuclear translocator (ARNT, also known as HIF1beta) in the liver

51 y functioning as a spacer to which cytosolic translocators can bind.

52 anism as a route to binding their far larger translocator cargo.

53 is renders SepL a high-affinity receptor for translocator/chaperone pairs, recognizing specific chape

54 Although all translocator chaperones dimerize, the location of the di

55 Given the crucial role of the translocator chaperones, we investigated the conformatio

56 plasm and its delivery to the inner membrane translocator ComEC.

57 ing the functional interchangeability of the translocator components of the T3SA of Shigella, Salmone

58 ive secretion and thus pore formation of the translocators depend on their binding to and being trans

59 the plastidial phosphoenolpyruvate/phosphate translocator, displayed a trade off between seed size an

60 In a second, SepD-coupled step, translocators docked on SepL become secreted.

61 e periplasm support the possibility that the translocator domain must undergo extensive folding prior

62 A SPATE polypeptide contains a C-terminal translocator domain that inserts into the bacterial oute

63 AipA and 76 aa in TaaP are homologous to the translocator domains of YadA from Yersinia enterocolitic

64 nt helicase activity, may also act as an RNA translocator during assembly of the primary replicase co

65 These novel export signals establish the translocator-effector secretion hierarchy, which in turn

66 in (ehbK and ehbL, respectively), and an ion translocator (ehbF).

67 important for substrate binding or targeting translocators for export.

68 How these translocators form a translocon in the lipid bilayer and

69 We have found that when added together, the translocators formed distinct hetero-complexes containin

70 studied, structural data on the hydrophobic translocators from the T3SS family remain elusive.

71 Previously, we showed that Sap translocator function is necessary for nontypeable Haemo

72 exported T3SS proteins including the needle, translocator, gate-keeper and effector.

73 a subunit, aryl hydrocarbon receptor nuclear translocator (HIFbeta/Arnt).

74 ively controls the secretion of the putative translocator HrpK and the type III effector Eop1.

75 secrete the harpins HrpW1 and HopAK1 or the translocator HrpK1, suggesting that these proteins are r

76 med from two large membrane proteins called "translocators." Importantly, effective secretion and thu

77 ial steps of insertion and assembly of these translocators in the membrane.

78 proteins require protein machineries called translocators in the outer and inner membranes for impor

79 membrane pores by dilution of urea-denatured translocators in the presence of membranes.

80 In this work we characterize PopB, the major translocator, in both membrane-associated and PcrH-bound

81 Feedback inhibition does not involve translocator insertion nor pore-formation.

82 support the hypothesis that the hydrophobic translocator (IpaB in Shigella) likely binds to a region

83 of a tip protein, IpaD, and two pore-forming translocators, IpaB and IpaC.

84 ch the heart-muscle-brain adenine nucleotide translocator isoform 1 (ANT1) was inactivated.

85 udies on Glucose-6-phosphate (G6P)/phosphate translocator isoforms GPT1 and GPT2 reported the viabili

86 Down-regulation of AhR nuclear translocator levels using short interfering RNA in a hum

87 and muscle aryl hydrocarbon receptor nuclear translocator like 1 (BMAL1) and reducing its ubiquitylat

88 of FLRL2, aryl-hydrocarbon receptor nuclear translocator-like (Arntl), and sirtuin 1 (Sirt1) express

89 activators aryl hydrocarbon receptor nuclear translocator-like (Bmal1) alone, or circadian locomotor

90 activator aryl hydrocarbon receptor nuclear translocator-like (Bmal1) from smooth muscle, but not fr

91 hm-related aryl hydrocarbon receptor nuclear translocator-like 2 (Arntl2) gene has been identified as

92 and muscle aryl hydrocarbon receptor nuclear translocator-like protein (BMAL)-1 constitutes a major t

93 and muscle aryl hydrocarbon receptor nuclear translocator-like:luciferase ( BMAL:LUC)], and biolumine

94 scle ARNT [aryl hydrocarbon receptor nuclear translocator]-like protein 1)-results in accelerated agi

95 PHT2;1 is one of the transporters/translocators mediating Pi import into chloroplasts.

96 The molecular identity of the MPD translocator (MPD flippase) is not known.

97 of MxiC regulation as follows: secretion of translocators, MxiC and/or effectors.

98 te/phosphate antiporter GPT1 as the putative translocator of Glc-6-phosphate for starch biosynthesis

99 -dependent anion channel (VDAC), the protein translocator of the outer membrane 40 (TOM40), or the fu

100 DNA translocators of natural transformation systems are comp

101 rium mutants as surrogates for expression of translocator orthologs identified from an extensive phyl

102 Further, the Sap translocator permease mediated heme transport into the b

103 Pseudomonas aeruginosa translocators PopB and PopD insert pores into membranes

104 rane pore formed by two T3S secreted protein translocators, PopB and PopD.

105 y into eukaryotic cells after assembly of a 'translocator' pore in the host plasma membrane.

106 The Class I mutant secretes translocators prematurely and is specifically defective

107 The PET radioligand (11)C-PBR28 targets translocator protein (18 kDa) (TSPO) and is a potential

108 The translocator protein (18 kDa) (TSPO) is described as a b

109 some BDZs also bind mitochondrial receptors [translocator protein (18 kDa) (TSPO)] and promote the sy

110 Translocator protein (18 kDa), known as TSPO, is a recog

111 phy/magnetic resonance imaging data of 18kDa translocator protein (an inflammatory marker) in MWA pat

112 ectional design using (18)F-FDG (n = 43) and translocator protein (TSPO) ((18)F-GE180; n = 58) small-

113 e ((18)F-PBR06) for detecting alterations in translocator protein (TSPO) (18 kDa), a biomarker of mic

114 Translocator protein (TSPO) (18 kDa), a marker of inflam

115 ivated, microglia increase the expression of translocator protein (TSPO) 18 kDa, thereby making the T

116 wth, inflammation, and invasion, such as the translocator protein (TSPO) and matrix metalloproteinase

117 In glioblastoma multiforme (GBM), translocator protein (TSPO) and murine double minute (MD

118 althy volunteers, genetically stratified for translocator protein (TSPO) binding status, underwent PE

119 es the first comprehensive quantification of translocator protein (TSPO) binding using SPECT and 6-ch

120 Ligands of the translocator protein (TSPO) elicit pleiotropic neuroprot

121 PET imaging with 18-kDa translocator protein (TSPO) enables longitudinal monitor

122 11C-PBR28 PET can detect the 18-kDa translocator protein (TSPO) expressed within macrophages

123 line class was exploited to search for a new translocator protein (TSPO) fluorescent probe endowed wi

124 et al. reported on a crystal structure for a translocator protein (TSPO) from Rhodobacter sphaeroides

125 adiolabeled ligands selective for the 18 kDa translocator protein (TSPO) has become the most widely u

126 nt of neuroinflammation agents targeting the translocator protein (TSPO) has been hindered by a commo

127 The mitochondrial translocator protein (TSPO) has been implicated in CNS d

128 Elevated expression of translocator protein (TSPO) has been shown to predict di

129 The 18-kDa translocator protein (TSPO) has been used in PET as an i

130 ssion tomography (PET) imaging of the 18 kDa translocator protein (TSPO) has been used to investigate

131 PET radioligands targeting the 18-kDa translocator protein (TSPO) have been used as in vivo ma

132 ective of this study was to evaluate whether translocator protein (TSPO) imaging could be used to vis

133 Here we compare translocator protein (TSPO) imaging using 6-chloro-2-(4'

134 PET radioligand binding to the 18-kD translocator protein (TSPO) in the brains of patients wi

135 The translocator protein (TSPO) is a commonly used imaging t

136 Increased expression of translocator protein (TSPO) is a feature of microglial a

137 Translocator protein (TSPO) is a key member of the mitoc

138 Translocator protein (TSPO) is expressed at a low level

139 The 18 kDa translocator protein (TSPO) is increasingly used to stud

140 The 18-kDa mitochondrial translocator protein (TSPO) is upregulated in high-grade

141 in-3-yl)-N,N-die thylacetamide (6b), a novel translocator protein (TSPO) ligand exhibiting a 36-fold

142 4-phenylquinazoline-2-carboxamide series of translocator protein (TSPO) ligands have been explored f

143 It remains unclear how different translocator protein (TSPO) ligands reflect the spatial

144 ol-3-ylglyoxylamides as potent and selective translocator protein (TSPO) ligands, two subsets of nove

145 5 PET, which aims to image expression of the translocator protein (TSPO) on activated microglia in th

146 nificant role in Alzheimer disease (AD), and translocator protein (TSPO) PET imaging allows us to qua

147 -L-DOPA, 6-[(18)F]fluoro-m-tyrosine, and the translocator protein (TSPO) PET ligand [(18)F]DAA1106.

148 -G-F) , and APPswe) together with 136 18-kDa translocator protein (TSPO) PET scans for microglial act

149 Since 18-kDa translocator protein (TSPO) plays an important role in r

150 PET imaging of the 18-kDa translocator protein (TSPO) provides a biomarker for mic

151 On the one hand, the translocator protein (TSPO) radioligand N,N-diethyl-2-(2

152 sclerosis (ALS) and can be visualized using translocator protein (TSPO) radioligands.

153 a-isosters of PK11195, the well-known 18 kDa translocator protein (TSPO) reference ligand, and synthe

154 se of SPECT/PET imaging agents targeting the translocator protein (TSPO) that is upregulated on activ

155 (11)C-PBR28 is a second-generation translocator protein (TSPO) tracer with characteristics

156 y-3-pyridinyl)acetamide) binds to the 18-kDa translocator protein (TSPO), a biomarker of glia.

157 we investigated the involvement and role of translocator protein (TSPO), a biomarker of microglial a

158 For PET imaging of 18-kDa translocator protein (TSPO), a biomarker of neuroinflamm

159 Ligands of the 18 kDa translocator protein (TSPO), a marker for activated micr

160 on tomography (PET) and radioligands for the translocator protein (TSPO), a marker for glial activati

161 re the binding of [(11)C]PBR28 to the 18 kDa translocator protein (TSPO), a marker for microglial act

162 PBR28, we quantified expression of the 18kDa translocator protein (TSPO), a marker of activated micro

163 PBR28, we show increased brain levels of the translocator protein (TSPO), a marker of glial activatio

164 Brain levels of 18-kDa translocator protein (TSPO), a marker of microglial acti

165 eration tracer for PET imaging of the 18-kDa translocator protein (TSPO), a marker of neuroinflammati

166 ssion Tomography brain imaging of the 18-kDa translocator protein (TSPO), a microglial biomarker, was

167 Translocator protein (TSPO), also referred to as periphe

168 The translocator protein (TSPO), an 18-kDa transmembrane pro

169 easured the in vivo expression of the 18 kDa translocator protein (TSPO), an activated glial marker e

170 the brain levels of the glial marker 18 kDa translocator protein (TSPO), and changes in functional c

171 l with high affinity and selectivity for the translocator protein (TSPO), expressed on activated glia

172 The mitochondrial protein, translocator protein (TSPO), is a widely used biomarker

173 Translocator protein (TSPO), previously known as the per

174 The translocator protein (TSPO), previously known as the per

175 The 18-kilodalton translocator protein (TSPO), proposed to be a key player

176 the effects of FGIN-1-27 were independent of translocator protein (TSPO), the reported target for thi

177 ssion tomography (PET) imaging of the 18 kDa translocator protein (TSPO), which is upregulated in act

178 Translocator protein (TSPO), which is upregulated in act

179 ivation can be detected in vivo using 18-kDa translocator protein (TSPO)-binding radioligands and PET

180 oidogenic acute regulatory protein (StAR) or translocator protein (TSPO).

181 tive inflammatory processes by targeting the translocator protein (TSPO).

182 vated expression of the 18 kDa mitochondrial translocator protein (TSPO).

183 binding associated with the 36 kDa dimer of translocator protein (TSPO).

184 mography (PET) radioligands that bind to the translocator protein (TSPO).

185 r developed for SPECT and targets the 18-kDa translocator protein (TSPO).

186 anied by a rapid up-regulation of the 18-kDa translocator protein (TSPO).

187 r gut expression of NADPH oxidase (NOX2) and translocator protein (TSPO).

188 Function of the mammalian translocator protein (TSPO; previously known as the peri

189 ur understanding of biological mechanisms of translocator protein 18 (TSPO) function but also indicat

190 ation is associated with increased levels of translocator protein 18 kDa (TSPO) and binding sites for

191 (PET) imaging with radiotracers that target translocator protein 18 kDa (TSPO) has become a popular

192 ssion tomography (PET) studies targeting the translocator protein 18 kDa (TSPO) have been limited by

193 In AD, the translocator protein 18 kDa (TSPO) is overexpressed in t

194 d can be monitored through expression of the translocator protein 18 kDa (TSPO) on activated microgli

195 PET imaging of translocator protein 18 kDa (TSPO) permits longitudinal,

196 ET imaging of brown adipose tissue (BAT) and translocator protein 18 kDa (TSPO) via a combination of

197 Translocator protein 18 kDa (TSPO), a biomarker of neuro

198 To measure translocator protein 18 kDa (TSPO), a marker of activate

199 ro evaluated for their potential to bind the translocator protein 18 kDa (TSPO), a protein today reco

200 ssion tomography with (11)C-PBR28 to measure translocator protein 18 kDa (TSPO), a putative biomarker

201 hat has been imaged extensively using PET is translocator protein 18 kDa (TSPO).

202 BR28 binds to the high-affinity state of the translocator protein 18 kDa (TSPO).

203 in 18 (TSPO) function but also indicate that translocator protein 18 may be a promising therapeutic t

204 AC-5216, XBD-173), a synthetic ligand of the translocator protein 18, ameliorates degeneration of dop

205 at is consistent with the biodistribution of translocator protein and yields a dose burden that is co

206 the healthy volunteers, suggesting increased translocator protein binding (z > 4.72).

207 n patients, and could explain the overlap in translocator protein binding values between patients wit

208 as to test for an association between 18 kDa translocator protein brain positron emission tomography

209 Translocator protein density increases when microglia ar

210 Translocator protein density measured by distribution vo

211 interaction between EspD and the hydrophilic translocator protein EspA.

212 The PET tracer 11C-PK11195 targets the translocator protein expressed by activated microglia an

213 Translocator protein genotyping allowed the classificati

214 fying the increased expression of the 18-kDa translocator protein have been developed.

215 recently showed microglia involvement using translocator protein imaging.

216 The reduction of (11)C-PBR28 binding to translocator protein in the brain of patients with Parki

217 tal sensor for triggering recruitment of the translocator protein IpaB to the needle tip.

218 GE180 for imaging activated microglia (18-kD translocator protein ligand [TSPO]) and static 30- to 60

219 microPET imaging of the stable binding of a translocator protein ligand suggested no radiation-speci

220 ement, were examined using a specific 18-kDa translocator protein ligand, (11)C-PBR28, and T1-weighte

221 Translocator protein of 18 kDa (TSPO) is a highly conser

222 e immune cell activation using (18)F-DPA-714 translocator protein PET and to explore the relationship

223 Glial activation in white matter assessed by translocator protein PET significantly improves predicti

224 Here we used the Pseudomonas aeruginosa translocator protein PopD as a model to identify its exp

225 progression using a second-generation 18-kDa translocator protein positron emission tomography radiot

226 sitron emission tomography scanning with the translocator protein radioligand 11C-PBR28 was performed

227 ivation in patients with MS using the 18-kDa translocator protein radioligand [(18)F]PBR111.

228 These results showed a positive translocator protein signal throughout the expansive hyp

229 Translocator protein total distribution volume (TSPO V(T

230 to compare (18)F-DPA714, a second-generation translocator protein tracer, with (11)C-JNJ717, a novel

231 ata for the structure of the A139T mutant of translocator protein TSPO from Rhodobacter sphaeroides s

232 Translocator protein TSPO is an 18 kDa protein implicate

233 istribution volume of (11)C-PBR28 binding to translocator protein was significantly reduced compared

234 (PET) radiotracer [11C]PBR28, which binds to translocator protein, a molecular marker that is up-regu

235 trigger recruitment of the first hydrophobic translocator protein, IpaB, to the tip complex where it

236 YopD, a translocator protein, represses the expression of T3SS g

237 The 18 kDa translocator protein, TSPO, is a cholesterol-binding pro

238 f (11)C-PBR28 to the microglia marker 18 kDa translocator protein, was examined using positron emissi

239 11)C](R)PK11195-PET measures upregulation of translocator protein, which is associated with microglia

240 We found higher translocator protein-binding in slow decliners than fast

241 here when PET imaging was performed with the translocator protein-binding radioligand (18)F-GE180.

242 Amyloidosis controls displayed higher translocator protein-binding than controls, especially i

243 f interest and voxel-wise comparison, 18-kDa translocator protein-binding was higher in high affinity

244 Translocator protein-binding was measured using a simple

245 Translocator protein-binding was positively correlated w

246 We used translocator protein-targeted molecular imaging to obtai

247 Translocator protein-targeted PET is a reliable tool for

248 de (DPA-714) is a radioligand for the 18-kDa translocator protein.

249 1 polymorphism in the gene encoding the 18Kd translocator protein.

250 a specific PET ligand for the assessment of translocator protein.

251 whether microglial activity, measured using translocator-protein positron emission tomography (PET)

252 Translocator proteins (TSPOs) bind steroids and porphyri

253 cterial cells HrpJ controls the secretion of translocator proteins and inside plant cells it suppress

254 iple systems indicates that the pore-forming translocator proteins are exported before effectors, but

255 T3SS translocator proteins are required for effector proteins

256 These translocator proteins are stabilized in the cytoplasm an

257 e secretion channel because the pore-forming translocator proteins can still be secreted while effect

258 ovide new insights into interactions between translocator proteins critical for virulence.

259 N terminus of the type III secretion system translocator proteins EspB, EspD, and EspA mediate prote

260 es pilus protein and no longer secretes four translocator proteins in culture, and it fails to inject

261 Translocator proteins include two hydrophobic proteins,

262 eruginosa, the chaperone of the pore-forming translocator proteins is PcrH.

263 pe III secretion systems rely on hydrophobic translocator proteins that form a pore in the host cell

264 To accomplish this, bacteria secrete translocator proteins that form a pore in the host-cell

265 The T3SS translocator proteins YopB and YopD form pores in host m

266 ecretion system, or with mutants lacking the translocator proteins, do not develop clinical disease,

267 Typhimurium chaperone and translocator proteins.

268 responded to oleic acid (OA) by using the FA translocator/receptor FAT/CD36 (CD36).

269 r secretion but that it is also required for translocator release.

270 complex with both type III secretion systems translocators, revealing that both molecules employ the

271 eased ADP-ATP exchange function and abnormal translocator reversal potential.

272 we reported on a novel structure of the DNA translocator secretin complex, PilQ, in Thermus thermoph

273 complete T3SS apparatus formation, a proper translocator secretion profile, and Shigella virulence.

274 ontact sensing with pilus length control and translocator secretion while also contributing to immuni

275 During translocator secretion, SepL/SepD suppress effector/chap

276 l passenger and an outer membrane C-terminal translocator, self-recognise in a Velcro-like handshake

277 he basic helix-loop-helix/period AhR nuclear translocator single minded family.

278 ted in schizophrenia after controlling for a translocator-specific genetic polymorphism.

279 e transporter ABCB4 is a phosphatidylcholine translocator specifically expressed at the bile canalicu

280 The hydrophobic translocator subunits of this system, PopB and PopD, hav

281 re composed of a 1.4-MDa pentameric membrane translocator (TcA) and a 250-kDa cocoon (TcB and TcC) en

282 gral pore, and the hydrophilic 'tip complex' translocator that connects the T3SS needle to the transl

283 ctin map to BamA, an essential chaperone and translocator that folds outer membrane proteins.

284 for a separate nearby outer membrane protein translocator that serves as a pathway into target cells.

285 mily: a cytosolic chaperone, two hydrophobic translocators that form a plasma membrane-integral pore,

286 ict hierarchical manner, for example, first "translocators", then "effectors".

287 act with membrane porins and a mitochondrial translocator to discover potential regulators of protein

288 ly deregulated in triose phosphate/phosphate translocator (tpt) mutants.

289 equired for insertion of the two hydrophobic translocators, VopB2 and VopD2, that constitute the memb

290 Unlike previously described hydrophilic translocators, VopW is itself translocated into the host

291 ng cells' resting potentials using other ion translocators, we show that a change in ectodermal volta

292 cell AHR levels, and the AHR and AHR nuclear translocator were required for optimal production of IL-

293 Translocators were purified as stable complexes with the

294 ependent anion channel or adenine nucleotide translocator, were reconstituted into lipid bilayers.

295 ly active heterodimer with ARNT (AHR nuclear translocator), which recognizes the dioxin response elem

296 vant chaperone proteins, and the AHR nuclear translocator, which heterodimerizes with the AHR to form

297 eral diffusion for binding sites on their OM translocators while bound to their primary OM receptor.

298 use the outer membrane porin, OmpF, as that translocator, while using a different primary receptor.

299 xport through the triose phosphate/phosphate translocator with subsequent MPK6 activation leading to

300 phagocytosis; furthermore, expression of the translocator YopB from intracellular bacteria also resul